Transformable Neuropeptide Prodrug with Tumor Microenvironment Responsiveness for Tumor Growth and Metastasis Inhibition of Triple‐Negative Breast Cancer

Triple‐negative breast cancer (TNBC) has the worst prognosis among all breast cancer subtypes due to lack of specific target sites and effective treatments. Herein, a transformable prodrug (DOX‐P18) based on neuropeptide Y analogue with tumor microenvironment responsiveness is developed for TNBC tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Yi, Ge, Xiaojiao, Zhu, Xueli, Han, Yingying, Wang, Pin, Akakuru, Ozioma Udochukwu, Wu, Aiguo, Li, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375191/
https://www.ncbi.nlm.nih.gov/pubmed/37147783
http://dx.doi.org/10.1002/advs.202300545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375191/
https://www.ncbi.nlm.nih.gov/pubmed/37147783
http://dx.doi.org/10.1002/advs.202300545

Ejemplares similares